Episode 30

Brain Biomarkers | Mild-Mod COVID Treatments

The JournalFeed podcast for the week of July 21-25, 2025.

These are summaries from just 2 of the 5 articles we cover every week! For access to more, please visit JournalFeed.org for details about becoming a member.



Monday Spoon Feed:

Novel blood-based biomarkers, specifically GFAP, UCH-L1, S100B, and NfL, may be well suited for early classification and triage of patients with acute and subacute minor traumatic brain injury.


Tuesday Spoon Feed:

To reduce hospitalizations of patients with mild to moderate COVID, treat with nirmatrelvir-ritonavir (Paxlovid) or remdesivir. To shorten the duration of COVID symptoms, azithroycin, favipiravir, molnupiravir, umifenovir, or corticosteroids may help, but they are not standard of care. 

Next Episode All Episodes Previous Episode

About the Podcast

Show artwork for JournalFeed
JournalFeed
The quickest way to keep up with emergency medicine literature!

Listen for free

About your hosts

Profile picture for Nicholas Zelt

Nicholas Zelt

The voice behind the mic! I'm an emergency medicine resident with a real nerdy love for podcasts and evidence based medicine. Joined the JournalFeed team way back in the before times (pre-COVID).
Profile picture for Clay Smith

Clay Smith

Hi! I've been practicing emergency medicine for over 20 years and started JournalFeed. I'm the Chief Spoon-Feeder, which means I either write or edit everything that's posted on the JournalFeed blog. But Nick totally runs the show with the podcast!